We are live on ! Find out more
VTRS icon

Viatris

1,022 hedge funds and large institutions have $9.67B invested in Viatris in 2022 Q1 according to their latest regulatory filings, with 100 funds opening new positions, 331 increasing their positions, 420 reducing their positions, and 140 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less call options, than puts

Call options by funds: $101M | Put options by funds: $101M

0.47% less ownership

Funds ownership: 73.92%73.44% (-0.47%)

5% less funds holding

Funds holding: 1,0711,022 (-49)

20% less capital invested

Capital invested by funds: $12.1B → $9.67B (-$2.43B)

21% less repeat investments, than reductions

Existing positions increased: 331 | Existing positions reduced: 420

29% less funds holding in top 10

Funds holding in top 10: 1410 (-4)

29% less first-time investments, than exits

New positions opened: 100 | Existing positions closed: 140

Holders
1,022
Holders Change
-49
Holders Change %
-4.58%
% of All Funds
16.07%
Holding in Top 10
10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-28.57%
% of All Funds
0.16%
New
100
Increased
331
Reduced
420
Closed
140
Calls
$101M
Puts
$101M
Net Calls
-$355K
Net Calls Change
-$61M

VTRS Hedge Fund Activity: Q1 2022 in Review

1,022 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q1 2022, worth a combined $9.67B — down 20% from $12.1B a quarter earlier.

Sellers outnumbered buyers: 140 funds closed out of VTRS and 100 opened new positions — a net loss of 40 holders — while 420 trimmed existing stakes and 331 added.

The largest buyer was Davis Selected Advisers, adding an estimated $155M. The largest seller was Macquarie Group, cutting an estimated $233M.

  • 1,022 institutional investors held Viatris (VTRS) as of Q1 2022, down from 1,071 in Q4 2021.
  • Funds reported $9.67B of Viatris stock for Q1 2022, down 20% quarter-over-quarter.
  • 100 funds opened new Viatris positions in Q1 2022 and 140 closed out, a net change of -40 holders.
  • The largest Viatris buyer in Q1 2022 was Davis Selected Advisers, an estimated $155M added.
  • The largest Viatris seller in Q1 2022 was Macquarie Group, an estimated $233M sold.

Based on aggregated 13F filings for Q1 2022.